Close Menu

NEW YORK — Proteomics International Laboratories said on Thursday that it has completed the transfer of the technology underlying its PromarkerD test for diabetic kidney disease to Irish clinical diagnostics firm Atturos.

According to Proteomics International, Atturos will make the mass spectrometry-based laboratory developed test available to licensing partners in Europe. Separately, Proteomics International announced today a deal with Patia Europe to launch the test in Spain as a laboratory-developed test through Atturos.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.